Skip to main content
Premium Trial:

Request an Annual Quote

CombiMatrix Molecular Diagnostics to Launch Service in US in August

NEW YORK, June 26 (GenomeWeb News) - CombiMatrix Molecular Diagnostics today said it plans to launch its first molecular diagnostic service in the USin August.

 

The service uses CMDX's Constitutional Genetic Array Test, which can genetically identify more than 50 "common" genetic disorders, including developmental disorders. The service is already sold in Europethrough Paris-based Array Genomics.

 

CMDX said it's in the "final phases" of internal human and clinical validation.

 

In March, CMDX and Array Genomics said they plan to co-develop and co-market a series of comparative genomic hybridization microarrays for diagnosing genetic anomalies associated with mental retardation, a developmental disorder.

 

Matt Watson, CEO of CMDX, said the subsidiary is "actively developing further tests based on both our oligo- and BAC capabilities that augment our microarray portfolio and over the next three quarters, we have plans to launch three to five additional products into the molecular diagnostics market."

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.